Abstract
Nowadays, there are no validated drugs to control the neuropathic pain induced by paclitaxel, one of the
most effective antineoplastic drugs.
The aim was to study the involvement of opioid and NMDA receptor on established paclitaxel-induced pain,
testing three common analgesics drugs morphine, ketamine and methadone.
Animals received four intraperitoneal (i.p.) injections on alternate days of paclitaxel (1 mg/kg). Three weeks
later, animals showed a mechanical and heat allodynia/hyperalgesia. Morphine (1, 2.5, 5 and 10 mg/kg)
abolished the reduction in the mechanical and thermal withdrawal thresholds in a dose dependent manner.
This effect was blocked by naloxone. Only highest dose of ketamine (50 mg/kg) was able to increase the
mechanical and thermal threshold and returned to basal values. Subanalgesic doses of morphine (1 mg/kg)
and ketamine (12.5 mg/kg) produced an additive effect on heat hyperalgesia reaching an antinociceptive
effect. This combination did not induce any change on tactile allodynia. Methadone (2.5 and 5 mg/kg)
produced an analgesic effect that was completely antagonized by naloxone in both tests.
Our results confirm that: the activation of opioids receptor produced analgesia; the blockade of NMDA
receptors produce antinociception but at high doses with motor impairments and low doses of ketamine
enhancing the effect of opioids.
Journal Title
Journal ISSN
Volume Title
Publisher
ELSEVIER
DOI
Date
Description
Keywords
Citation
PHARMACOOL BIOCHEM BEHAV 95(3) 331-337
Collections
Endorsement
Review
Supplemented By
Referenced By
Document viewer
Select a file to preview:
Reload



